Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carnitine as Adjunct to Methylphenidate for ADHD
NCT01099072Phase 2Unknown
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetyl-l-carnitine in attention deficit hyperactivity disorder (ADHD), sponsored by Tehran University of Medical Sciences. Status: unknown.
02
Drugs
acetyl-l-carnitine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01099072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01099072.